drugs used to treat bacterial infections Flashcards
(45 cards)
beta-lactams contain 4 classes of abx
o Penicillins
o Cephalosporins
o Carbapenems
o Monobactams
MOA beta-lactams
- Beta-lactams inhibit the biosynthesis of the bacterial cell wall, specifically the peptidoglycan structure
o Beta-lactams bind to these penicillin binding proteins and this inhibits cell wall synthesis and leads to cell lysis
penicillins are active againts:
Active against aerobic, gram + organisms
- Streptococcus
- Some Enterococcus strains
- Non-penicillinase-producing staphylococci
beta-lactamases
a large group of enzymes w/ diverse ability to inactivate beta-lactams
clinical use for penicillins
- URIs (Pharyngitis, Otitis media, and Sinusitis)
- Pneumonia
- STIs
- UTIs
- Wound infections
Other important indications:
* Endocarditis prophylaxis
* Eradication of H. pylori in gastritis and PUD
* Lyme disease
pharmacodynamics of cephalosporins
Inhibit mucopeptide synthesis in the bacterial cell wall, making the bacterium osmotically unstable
* Inhibit PBPs involved in cross-linking peptidoglycans in the cell wall
clinical use of cephalosporins
Active against many respiratory pathogens, including:
Those that cause acute otitis media
Sinusitis
Group A streptococcal pharyngitis
Pneumonia
Chronic bronchitis
o Active against many pathogens that cause UTIs
o Ceftriaxone IM is the recommended treatment for gonorrhea
o Staphylococcal skin infections often respond to first generation cephalosporins such as cephalexin
older group of fluroquinolones
Ciprofloxacin (Cipro)
Ofloxacin (Floxin)
newer group of fluroquinolones
Levofloxacin (Levaquin)
Moxifloxacin (Avelox)
Delafloxacin (Baxdela)
what is the newer group of fluroquinolones known as:
the respiratory fluroquinolones
pharmacodynamics of fluroquinolones
- Fluroquinolones are bactericidal through interference with enzymes required for the synthesis and repair of bacterial DNA
- The fluorine molecule added to create the fluroquinolones provides increased potency against gram – organisms and broadens the spectrum to include gram + organisms as well
- Fluoroquinolones inhibit bacterial topoisomerase II (DNA gyrase) and topoisomerase IV
what bacteria does fluroquinolones work against?
notable for their extensive gram negative activity:
- E. coli
- Klebsiella
- Enterobacter
- Campylobacter
- Salmonella
- Shigella
- Proteus
- Serratia
- Haemophilus
- N. gonorrheae
- N. meningitidis
- M. catahhalis
boxed warning for fluroquinolones
risk of tendon rupture and tendonitis
clinical use of fluroquinolones
used to treat a variety of infections but d/t resistance, are no longer considered 1st line treatments
* resp fluroquinolones are used for CAP
pharmacodynamics of clindamycin
binds to the 50S subunit of the bacterial ribosome and suppresses protein synthesis
clindamycin susceptible organisms
primarily gram positive organisms, but also effective against selected anaerboic pathogens
- Strep pyogenes
- Strep viridians
- S. aureus
- Corynebacterium diphtheria
- Corynebacterium acnes
AND
- Bacteroides
- Fusobacterium
- Actinomyces
- Peptocuccus
- Prevotella
- Clostridium perfringens
- Clostridium tetani
clinical use for clindamycin
- used for 1st line therapy for serious infections treated parenterally in the hospital
- 1st line tx for MRSA
tx of infectoins for those with PCN allergies - drug resistant pneumococcal infections
- bacterial vaginalis
macrolides and azalides
compounds characterized by a macrocyclic lactone ring with deoxy sugars attached
macrolide drugs
- erythromycin
- clarithromycin (Biaxin)
- azithromycin (Zithromax)
pharmacodynamics of macrolides
- reversibly binds to the P site of the 50S ribosomal subunit of susceptible organisms
- may inhibit RNA-dependent protein synthesis by stimulating the dissociation of peptidyl-tRNA from ribosomes
- these drugs are typically bacteriostatic depending on drug concentrations and the bacterial species tested
organisms susceptible to macrolides
active against gram + organisms and some gram negative
clinical use of macrolides
- CAP
- STIs
- H. pylori infections
- Endocarditis prophylaxis in those allergic to penicillins
- Off label uses for Lyme disease
Oxazolidinones
Linezolid (Zyvox) and tedizolid (Sivextro)
pharmacodynamics for oxazolidinones
- Inhibit bacterial ribosomal protein synthesis, but unlike other antibiotics, they stop the first step in synthesis in which bacteria assemble ribosomes from their dissociated subunits
- Effective against aerobic gram-positive bacteria
- Linezolid retains activity against the most resistant forms of Enterococcus including VRE